A Little Help from Friends | GenomeWeb

A Little Help from Friends

Premium

At the Windber Research Institute, not all studies follow the traditional medicine path — that a bench scientist comes up with a clinical test and then moves it to the bedside. Instead, these researchers start in the clinic, find a niche that needs to be filled or re-examined, and then head back to the bench to develop a solution that is subsequently pushed forward into the clinic. It’s a more circular path, and one that represents the field’s hope for the promise of translational medicine.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

Startup companies are taking on personalized medicine, CNET reports.

Bruce Booth writes at Life Sci VC that biotech clusters like Boston and San Francisco are getting even more consolidated.

The Verge speaks with Mark and Scott Kelly, who are the subjects of NASA's Twin Study.

In Genome Biology this week: genes linked to Hirschsprung disease, structural variant patterns in autism, and more.